Celltrion has announced the acquisition of iQone Healthcare Switzerland, a specialty pharmaceutical company, to further build its expertise and foothold in Europe. The acquisition represents a strategic shift in Celltrion’s growth strategy, leveraging acquisitions to accelerate its European expansion and access in-licensing opportunities.
Company Information
Company
Celltrion
Location
Incheon, Seoul, South Korea
About
Celltrion is a leading biopharmaceutical company based in Incheon, South Korea that specialises in researching, developing, manufacturing, marketing and sales of innovative therapeutics that improve people's lives worldwide. The company’s solutions include world-class monoclonal antibody biosimilars such as Remsima®, Truxima® and Herzuma®, providing broader patient access globally. Celltrion has also received U.S. FDA and EC approval for several products, enhancing its portfolio in the biopharmaceutical industry.
IncheonManufacturingBiotechnologyTherapeuticsPharmaceuticalBiopharma